Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Lifestyle
Rebecca Whittaker

What we know about Foundayo - the new weight loss pills to be approved in UK

  • Foundayo, a daily GLP-1 weight loss pill produced by Eli Lilly, has been approved in the UK for treating both weight loss and type 2 diabetes.
  • The UK is the first country in Europe to approve the drug for both conditions, although it will only be available via private prescription and not on the NHS.
  • Unlike rival oral treatment Wegovy, Foundayo can be taken once daily without any food or water restrictions.
  • The drug is set to launch in the UK later this month at a lower list price than Mounjaro, which currently costs £330 for a monthly supply.
  • While offering clinically meaningful weight loss, potential side effects of the medication include nausea, diarrhoea, stomach cramps, fatigue, and hair loss.

IN FULL

Foundayo: The new weight loss pill approved for the UK

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.